Quick Answer
INSMED Inc reported Revenue (ASC 606) of $606.42 million for fiscal year 2025.
INSMED Inc Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $606.42M | +66.7% |
| 2024 | $363.71M | +19.2% |
| 2023 | $305.21M | +24.4% |
| 2022 | $245.36M | +30.2% |
| 2021 | $188.46M | +14.6% |
| 2020 | $164.41M | +20.5% |
| 2019 | $136.47M | +1287.6% |
| 2018 | $9.84M | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $142.34M | +52.4% | +32.5% |
| June 30, 2025 | $107.42M | +18.9% | +15.7% |
| March 31, 2025 | $92.82M | +22.9% | -0.6% |
| September 30, 2024 | $93.42M | +18.2% | +3.4% |
| June 30, 2024 | $90.34M | +17.0% | +19.7% |
| March 31, 2024 | $75.50M | +15.8% | -4.5% |
| September 30, 2023 | $79.07M | +16.7% | +2.4% |
| June 30, 2023 | $77.23M | +18.4% | +18.4% |
- INSMED Inc showed an increase of +66.7% in Revenue (ASC 606) compared to the prior fiscal year.
- The most recent figure is from INSMED Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: